Investigation of potential FCPA violations by several non-U.S. operating subsidiaries of a Fortune 10 company, resulting in voluntary disclosure to the DOJ and SEC (with no adverse action taken), several follow-on investigations of operations in Central and South America, and ongoing involvement in related reviews across the company’s operations worldwide.
Conducting a global anticorruption review of one of the world’s leading multinational medical device manufacturers in connection with its acquisition by a Fortune 500 pharmaceutical and medical device company in a multibillion-dollar transaction.
Assisting a Fortune 500 mixed industrial client in overseeing a due diligence program covering more than 300 third-party agents, distributors and other company representatives across multiple lines of business operating in dozens of countries.
Ongoing representation of a Fortune 500 energy company on export control and other compliance matters, including revising policies, procedures, contractual provisions and screening tools with regard to trade restrictions, export controls and FCPA/anticorruption concerns.
Representation of a privately-held international commodity trading company in a grand jury investigation involving the EPA and the U.S. Attorney’s Office for the Southern District of Texas regarding alleged environmental violations in connection with the export of certain petroleum products from the United States, and subsequent disposal of related materials outside the United States.
Representation of an international Fortune 500 food manufacturer in a joint investigation by the EPA, the Ohio Attorney General’s Office and state and local environmental regulators of whistleblower allegations at the Ohio processing facility of a company subsidiary.
Representation of an international Fortune 500 mixed industrial manufacturer in a joint investigation by the U.S. Attorney’s Offices for the Western District of Virginia and the District of Massachusetts and alleged false statements related to a defense-related government contract.
Representation of a doctor and his company in one of the largest Medicare fraud cases brought in Virginia as of that date, which was prosecuted by the U.S. Attorney’s Office for the Eastern District of Virginia.